Editas Medicine appoints Andrew Hirsch to board
Mr. Hirsch will also serve as chairman of the audit committee of the board.
He is currently Chief Financial Officer of Agios Pharmaceuticals.
Mr. Hirsch has more than 20 years of experience in a range of strategic and operating roles in business, including more than 15 years in the biotech industry.
Prior to his current role at Agios, Mr. Hirsch served as president and chief executive officer of BIND Therapeutics.
Earlier in his career, he held various leadership roles at Avila Therapeutics and Biogen. ■